Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.

Identifieur interne : 002B16 ( PubMed/Curation ); précédent : 002B15; suivant : 002B17

An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.

Auteurs : P. Murthi [Australie] ; S. Brouillet [France] ; A. Pratt [Australie] ; Aj Borg [Australie] ; B. Kalionis [Belgique] ; F. Goffin [Belgique] ; V. Tsatsaris [France] ; C. Munaut [Belgique] ; Jj Feige [France] ; M. Benharouga [France] ; T. Fournier [France] ; N. Alfaidy [France]

Source :

RBID : pubmed:26208047

Abstract

Idiopathic fetal growth restriction (FGR) is frequently associated with placental insufficiency. Previous reports have provided evidence that EG-VEGF (endocrine gland derived-vascular endothelial growth factor), a placental secreted protein, is expressed during the first trimester of pregnancy, controls both trophoblast proliferation and invasion, and its increased expression is associated with human FGR. In this study, we hypothesise that EG-VEGF-dependent change in placental homeobox gene expressions contribute to trophoblast dysfunction in idiopathic FGR. The changes in EG-VEGF-dependent homeobox gene expressions were determined using a Homeobox gene cDNA array on placental explants of 8-12 weeks' gestation after stimulation with EG-VEGF in vitro for 24 hours. The Homeobox gene array identified a >5-fold increase in HOXA9, HOXC8, HOXC10, HOXD1, HOXD8, HOXD9 and HOXD11, while NKX 3.1 showed a >2 fold-decrease in mRNA expression compared to untreated controls. Homeobox gene NKX3.1 was selected as a candidate because it is a downstream target of EG-VEGF and its expression and functional role are largely unknown in control and idiopathic FGR-affected placentae. Real-time PCR and immunoblotting showed a significant decrease in NKX3.1 mRNA and protein levels, respectively, in placentae from FGR compared to control pregnancies. Gene inactivation in vitro using short-interference RNA specific for NKX3.1 demonstrated an increase in BeWo cell differentiation and a decrease in HTR8-SVneo proliferation. We conclude that the decreased expression of homeobox gene NKX3.1 down-stream of EG-VEGF may contribute to the trophoblast dysfunction associated with idiopathic FGR pregnancies.

DOI: 10.2119/molmed.2015.00071
PubMed: 26208047

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26208047

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.</title>
<author>
<name sortKey="Murthi, P" sort="Murthi, P" uniqKey="Murthi P" first="P" last="Murthi">P. Murthi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brouillet, S" sort="Brouillet, S" uniqKey="Brouillet S" first="S" last="Brouillet">S. Brouillet</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<wicri:orgArea>Institut National de la Santé et de la Recherche Médicale, Unité 1036</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Pratt, A" sort="Pratt, A" uniqKey="Pratt A" first="A" last="Pratt">A. Pratt</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Borg, Aj" sort="Borg, Aj" uniqKey="Borg A" first="Aj" last="Borg">Aj Borg</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kalionis, B" sort="Kalionis, B" uniqKey="Kalionis B" first="B" last="Kalionis">B. Kalionis</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Tumor and Developmental Biology University of Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Goffin, F" sort="Goffin, F" uniqKey="Goffin F" first="F" last="Goffin">F. Goffin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Tumor and Developmental Biology University of Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Tsatsaris, V" sort="Tsatsaris, V" uniqKey="Tsatsaris V" first="V" last="Tsatsaris">V. Tsatsaris</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Hôpital Cochin, Maternité Port-Royal, Université Rene Descartes, F-75014 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Hôpital Cochin, Maternité Port-Royal, Université Rene Descartes, F-75014 Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Munaut, C" sort="Munaut, C" uniqKey="Munaut C" first="C" last="Munaut">C. Munaut</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Tumor and Developmental Biology University of Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Feige, Jj" sort="Feige, Jj" uniqKey="Feige J" first="Jj" last="Feige">Jj Feige</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<wicri:orgArea>Institut National de la Santé et de la Recherche Médicale, Unité 1036</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Benharouga, M" sort="Benharouga, M" uniqKey="Benharouga M" first="M" last="Benharouga">M. Benharouga</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5249, Laboratoire de Chimie et Biologie des Métaux, Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5249, Laboratoire de Chimie et Biologie des Métaux, Grenoble</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fournier, T" sort="Fournier, T" uniqKey="Fournier T" first="T" last="Fournier">T. Fournier</name>
<affiliation wicri:level="1">
<nlm:affiliation>INSERM, U1139, Paris, F-75006, France, Universite Paris Descartes, UMR-S1139, Sorbonne Paris Cite, Paris, F-75006, France, PremUp Foundation, Paris, F-75006, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, U1139, Paris, F-75006, France, Universite Paris Descartes, UMR-S1139, Sorbonne Paris Cite, Paris, F-75006, France, PremUp Foundation, Paris, F-75006</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alfaidy, N" sort="Alfaidy, N" uniqKey="Alfaidy N" first="N" last="Alfaidy">N. Alfaidy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<wicri:orgArea>Institut National de la Santé et de la Recherche Médicale, Unité 1036</wicri:orgArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26208047</idno>
<idno type="pmid">26208047</idno>
<idno type="doi">10.2119/molmed.2015.00071</idno>
<idno type="wicri:Area/PubMed/Corpus">002B89</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B89</idno>
<idno type="wicri:Area/PubMed/Curation">002B16</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B16</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.</title>
<author>
<name sortKey="Murthi, P" sort="Murthi, P" uniqKey="Murthi P" first="P" last="Murthi">P. Murthi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brouillet, S" sort="Brouillet, S" uniqKey="Brouillet S" first="S" last="Brouillet">S. Brouillet</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<wicri:orgArea>Institut National de la Santé et de la Recherche Médicale, Unité 1036</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Pratt, A" sort="Pratt, A" uniqKey="Pratt A" first="A" last="Pratt">A. Pratt</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Borg, Aj" sort="Borg, Aj" uniqKey="Borg A" first="Aj" last="Borg">Aj Borg</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kalionis, B" sort="Kalionis, B" uniqKey="Kalionis B" first="B" last="Kalionis">B. Kalionis</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Tumor and Developmental Biology University of Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Goffin, F" sort="Goffin, F" uniqKey="Goffin F" first="F" last="Goffin">F. Goffin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Tumor and Developmental Biology University of Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Tsatsaris, V" sort="Tsatsaris, V" uniqKey="Tsatsaris V" first="V" last="Tsatsaris">V. Tsatsaris</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Obstetrics and Gynecology, Hôpital Cochin, Maternité Port-Royal, Université Rene Descartes, F-75014 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Obstetrics and Gynecology, Hôpital Cochin, Maternité Port-Royal, Université Rene Descartes, F-75014 Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Munaut, C" sort="Munaut, C" uniqKey="Munaut C" first="C" last="Munaut">C. Munaut</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Tumor and Developmental Biology University of Liège</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Feige, Jj" sort="Feige, Jj" uniqKey="Feige J" first="Jj" last="Feige">Jj Feige</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<wicri:orgArea>Institut National de la Santé et de la Recherche Médicale, Unité 1036</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Benharouga, M" sort="Benharouga, M" uniqKey="Benharouga M" first="M" last="Benharouga">M. Benharouga</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5249, Laboratoire de Chimie et Biologie des Métaux, Grenoble, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5249, Laboratoire de Chimie et Biologie des Métaux, Grenoble</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fournier, T" sort="Fournier, T" uniqKey="Fournier T" first="T" last="Fournier">T. Fournier</name>
<affiliation wicri:level="1">
<nlm:affiliation>INSERM, U1139, Paris, F-75006, France, Universite Paris Descartes, UMR-S1139, Sorbonne Paris Cite, Paris, F-75006, France, PremUp Foundation, Paris, F-75006, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, U1139, Paris, F-75006, France, Universite Paris Descartes, UMR-S1139, Sorbonne Paris Cite, Paris, F-75006, France, PremUp Foundation, Paris, F-75006</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alfaidy, N" sort="Alfaidy, N" uniqKey="Alfaidy N" first="N" last="Alfaidy">N. Alfaidy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Grenoble</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
<wicri:orgArea>Institut National de la Santé et de la Recherche Médicale, Unité 1036</wicri:orgArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Molecular medicine (Cambridge, Mass.)</title>
<idno type="eISSN">1528-3658</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Idiopathic fetal growth restriction (FGR) is frequently associated with placental insufficiency. Previous reports have provided evidence that EG-VEGF (endocrine gland derived-vascular endothelial growth factor), a placental secreted protein, is expressed during the first trimester of pregnancy, controls both trophoblast proliferation and invasion, and its increased expression is associated with human FGR. In this study, we hypothesise that EG-VEGF-dependent change in placental homeobox gene expressions contribute to trophoblast dysfunction in idiopathic FGR. The changes in EG-VEGF-dependent homeobox gene expressions were determined using a Homeobox gene cDNA array on placental explants of 8-12 weeks' gestation after stimulation with EG-VEGF in vitro for 24 hours. The Homeobox gene array identified a >5-fold increase in HOXA9, HOXC8, HOXC10, HOXD1, HOXD8, HOXD9 and HOXD11, while NKX 3.1 showed a >2 fold-decrease in mRNA expression compared to untreated controls. Homeobox gene NKX3.1 was selected as a candidate because it is a downstream target of EG-VEGF and its expression and functional role are largely unknown in control and idiopathic FGR-affected placentae. Real-time PCR and immunoblotting showed a significant decrease in NKX3.1 mRNA and protein levels, respectively, in placentae from FGR compared to control pregnancies. Gene inactivation in vitro using short-interference RNA specific for NKX3.1 demonstrated an increase in BeWo cell differentiation and a decrease in HTR8-SVneo proliferation. We conclude that the decreased expression of homeobox gene NKX3.1 down-stream of EG-VEGF may contribute to the trophoblast dysfunction associated with idiopathic FGR pregnancies.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">26208047</PMID>
<DateCreated>
<Year>2015</Year>
<Month>07</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1528-3658</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2015</Year>
<Month>Jul</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Molecular medicine (Cambridge, Mass.)</Title>
<ISOAbbreviation>Mol. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.2119/molmed.2015.00071</ELocationID>
<Abstract>
<AbstractText>Idiopathic fetal growth restriction (FGR) is frequently associated with placental insufficiency. Previous reports have provided evidence that EG-VEGF (endocrine gland derived-vascular endothelial growth factor), a placental secreted protein, is expressed during the first trimester of pregnancy, controls both trophoblast proliferation and invasion, and its increased expression is associated with human FGR. In this study, we hypothesise that EG-VEGF-dependent change in placental homeobox gene expressions contribute to trophoblast dysfunction in idiopathic FGR. The changes in EG-VEGF-dependent homeobox gene expressions were determined using a Homeobox gene cDNA array on placental explants of 8-12 weeks' gestation after stimulation with EG-VEGF in vitro for 24 hours. The Homeobox gene array identified a >5-fold increase in HOXA9, HOXC8, HOXC10, HOXD1, HOXD8, HOXD9 and HOXD11, while NKX 3.1 showed a >2 fold-decrease in mRNA expression compared to untreated controls. Homeobox gene NKX3.1 was selected as a candidate because it is a downstream target of EG-VEGF and its expression and functional role are largely unknown in control and idiopathic FGR-affected placentae. Real-time PCR and immunoblotting showed a significant decrease in NKX3.1 mRNA and protein levels, respectively, in placentae from FGR compared to control pregnancies. Gene inactivation in vitro using short-interference RNA specific for NKX3.1 demonstrated an increase in BeWo cell differentiation and a decrease in HTR8-SVneo proliferation. We conclude that the decreased expression of homeobox gene NKX3.1 down-stream of EG-VEGF may contribute to the trophoblast dysfunction associated with idiopathic FGR pregnancies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Murthi</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Medicine, Monash University, Clayton, Victoria 3168, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brouillet</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Univ. Grenoble-Alpes, 38000, Grenoble, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), iRTSV-Biology of Cancer and infection, Grenoble, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Centre Hospitalier Universitaire de Grenoble, Hôpital Couple-Enfant, Centre Clinique et Biologique d'Assistance Médicale à la Procréation, 38700, La Tronche, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pratt</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Borg</LastName>
<ForeName>Aj</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Perinatal Medicine Pregnancy Research Centre, The Royal Women's Hospital and The University of Melbourne Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Parkville, Victoria 3052, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kalionis</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goffin</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tsatsaris</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Obstetrics and Gynecology, Hôpital Cochin, Maternité Port-Royal, Université Rene Descartes, F-75014 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Munaut</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Tumor and Developmental Biology University of Liège, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Feige</LastName>
<ForeName>Jj</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Univ. Grenoble-Alpes, 38000, Grenoble, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), iRTSV-Biology of Cancer and infection, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Benharouga</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5249, Laboratoire de Chimie et Biologie des Métaux, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fournier</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>INSERM, U1139, Paris, F-75006, France, Universite Paris Descartes, UMR-S1139, Sorbonne Paris Cite, Paris, F-75006, France, PremUp Foundation, Paris, F-75006, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alfaidy</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Institut National de la Santé et de la Recherche Médicale, Unité 1036, Grenoble. France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Univ. Grenoble-Alpes, 38000, Grenoble, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Commissariat à l'Energie Atomique (CEA), iRTSV-Biology of Cancer and infection, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Med</MedlineTA>
<NlmUniqueID>9501023</NlmUniqueID>
<ISSNLinking>1076-1551</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2011 Oct;32(10):745-51</RefSource>
<PMID Version="1">21802725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Fetal Neonatal Med. 2004 Oct;9(5):395-401</RefSource>
<PMID Version="1">15691775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2013 Oct;19(10):665-75</RefSource>
<PMID Version="1">23761267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Clin Nutr. 2000 May;71(5 Suppl):1344S-52S</RefSource>
<PMID Version="1">10799412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2007 Oct;28(10):1049-58</RefSource>
<PMID Version="1">17531315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2014 Aug;20(8):810-9</RefSource>
<PMID Version="1">24867328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2006 May;12(5):335-40</RefSource>
<PMID Version="1">16613891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2007 Apr;28 Suppl A:S64-9</RefSource>
<PMID Version="1">17349689</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ginekol Pol. 2009 Sep;80(9):652-6</RefSource>
<PMID Version="1">19886237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2006 Apr;147(4):1675-84</RefSource>
<PMID Version="1">16384869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2010 Apr;31(4):347-50</RefSource>
<PMID Version="1">20207415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Life Sci. 2013 Feb;70(3):511-25</RefSource>
<PMID Version="1">22941044</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochem Cell Biol. 1992 Oct-Nov;70(10-11):867-74</RefSource>
<PMID Version="1">1297352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Obstet Gynecol. 1997 Dec;40(4):740-9</RefSource>
<PMID Version="1">9429788</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Intensive Care Med. 2004 Nov-Dec;19(6):307-19</RefSource>
<PMID Version="1">15523117</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Obstet Gynecol. 2002 Jul;187(1):24-32</RefSource>
<PMID Version="1">12114884</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>
<PMID Version="1">11846609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gynecol Oncol. 2003 Sep;90(3):512-8</RefSource>
<PMID Version="1">13678718</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Histochem Cell Biol. 1998 Nov;110(5):495-508</RefSource>
<PMID Version="1">9826129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Sci. 2014 Oct 1;127(Pt 19):4172-85</RefSource>
<PMID Version="1">25052094</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Fetal Diagn Ther. 2012;32(4):225-30</RefSource>
<PMID Version="1">22906990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Endocrinol Metab. 2003 Nov;88(11):5555-63</RefSource>
<PMID Version="1">14602804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2012 Feb;33 Suppl:S81-6</RefSource>
<PMID Version="1">22138060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cell Mol Med. 2009 Aug;13(8B):2224-35</RefSource>
<PMID Version="1">19602057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Androl. 2011 May-Jun;32(3):210-7</RefSource>
<PMID Version="1">20930191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2000 Mar-Apr;21 Suppl A:S50-4</RefSource>
<PMID Version="1">10831122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biol Reprod. 2010 Oct;83(4):676-83</RefSource>
<PMID Version="1">20554918</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Fetal Neonatal Med. 2004 Oct;9(5):357-69</RefSource>
<PMID Version="1">15691771</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Aust N Z J Obstet Gynaecol. 1994 Feb;34(1):39-50</RefSource>
<PMID Version="1">8053875</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Hum Reprod. 2006 Dec;12(12):763-9</RefSource>
<PMID Version="1">17062780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Reprod Immunol. 2010 Jun;63(6):492-505</RefSource>
<PMID Version="1">20236263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 1993 Jun;206(2):204-11</RefSource>
<PMID Version="1">7684692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2002 Feb-Mar;23(2-3):232-5</RefSource>
<PMID Version="1">11945091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2010 Aug;31(8):691-7</RefSource>
<PMID Version="1">20542333</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2001 Aug 30;412(6850):877-84</RefSource>
<PMID Version="1">11528470</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Endocrinology. 2007 Oct;148(10):5011-9</RefSource>
<PMID Version="1">17628005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Reproduction. 2010 Nov;140(5):759-66</RefSource>
<PMID Version="1">20696850</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ginekol Pol. 2007 Jul;78(7):521-6</RefSource>
<PMID Version="1">17915407</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2013 Apr;34(4):299-309</RefSource>
<PMID Version="1">23484914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drug Metab Dispos. 2007 Apr;35(4):595-601</RefSource>
<PMID Version="1">17237156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Med (Berl). 2012 Mar;90(3):273-84</RefSource>
<PMID Version="1">22113468</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Chem. 2008 Dec 11;51(23):7635-9</RefSource>
<PMID Version="1">19006379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2006 Feb;168(2):511-8</RefSource>
<PMID Version="1">16436665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2015 Apr;36 Suppl 1:S35-42</RefSource>
<PMID Version="1">25564303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(1):e54916</RefSource>
<PMID Version="1">23372791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2007 Jul;28(7):650-7</RefSource>
<PMID Version="1">17113145</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Obstet Gynecol. 2002 Jan;186(1):158-66</RefSource>
<PMID Version="1">11810103</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Biol Chem. 2002 May 31;277(22):19276-80</RefSource>
<PMID Version="1">11886876</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Obstet Gynecol Reprod Biol. 2000 Sep;92 (1):35-43</RefSource>
<PMID Version="1">10986432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Obstet Gynecol Reprod Biol. 2003 Sep 22;110 Suppl 1:S99-107</RefSource>
<PMID Version="1">12965097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Dev Biol. 2010;54(2-3):269-80</RefSource>
<PMID Version="1">19876833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biol Cell. 2010 Aug 15;21(16):2832-43</RefSource>
<PMID Version="1">20587779</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Cell Res. 1990 Feb;186(2):306-16</RefSource>
<PMID Version="1">2153559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Placenta. 2002 Apr;23 Suppl A:S119-29</RefSource>
<PMID Version="1">11978069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mech Dev. 2000 Jul;95(1-2):163-74</RefSource>
<PMID Version="1">10906459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Genes Dev. 1999 Apr 15;13(8):966-77</RefSource>
<PMID Version="1">10215624</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>7</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>7</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>7</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26208047</ArticleId>
<ArticleId IdType="pii">molmed.2015.00071</ArticleId>
<ArticleId IdType="doi">10.2119/molmed.2015.00071</ArticleId>
<ArticleId IdType="pmc">PMC4749495</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B16 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002B16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26208047
   |texte=   An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:26208047" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024